The Respiratory Specialty Group is one of 23
Specialty Groups which provide national networks
of topic-specific expertise. These groups are key to
the success of the CCRN. They work at both national
and local levels to ensure the successful delivery of
research within their specialties. This means ensuring
that studies are delivered to target and on time.
The Purpose of our group is;
- To ensure patients with respiratory disease can take part in respiratory clinical trials regardless of where they live.
- To work closely with NHS patients and carers to ensure that respiratory clinical trials are designed so that they can take part and will lead to benefits relevant to them.
- To help researchers work together to deliver trials efficiently and thereby ensure patients have access to effective new respiratory treatments as soon as possible.
- To promote the benefits of healthcare research to organisations and support new and established respiratory researchers.
- To work together with organisations representing patients and researchers to prioritise the respiratory research that will make the most difference to respiratory patients' lives.
- To support the life science industry in the UK with the benefits that provides to patients and the UK economy.
The Respiratory Specialty Group’s portfolio includes:
- Chronic obstructive pulmonary disease (COPD)
- Cystic fibrosis
- Interstitial lung disease
- Lung infections including tuberculosis
- Lung cancer
- Occupational lung disease
- Pleural disease
- Sleep and breathing disorders
- Disorders affecting the chest wall and respiratory muscles.
What we do
How we work with the life-sciences industry
How to get involved